Table 1 Free light chain (FLC) parameters from serum samples analysed using Seralite®
Median (range) | Myeloma AKI κ patients (n = 26) | Myeloma AKI λ patients (n = 19) | Non-myeloma AKI (n = 54) | Healthy donors (n = 91) |
|---|---|---|---|---|
κ FLC (mg/L) | 2193 (113–80,000) | 12 (4–91) | 36 (9–198) | 11 (4–37) |
λ FLC (mg/L) | 32 (8–110) | 2262 (163–80,000) | 94 (14–574) | 11 (3–31) |
κ:λ ratio | 81 (3–1103) | 0.006 (0–0.090) | 0.4 (0.2–1.3) | 1 (0.5–3.3) |
FLC sum (mg/L) | 2215 (131–80,073) | 2353 (174–80,017) | 134 (26–772) | 22 (10–68) |
dFLC (mg/L) | 2171 (96–79,928) | 2189 (152–79,984) | 57 (0–376) | 3 (0–12) |